Lasarettet I Motala Region Ostergotland
- Address
- Lasarettsgatan 37, 591 35 Motala, Sweden
Lasarettet I Motala Region Ostergotland
Lasarettet I Motala Region Ostergotland is a comprehensive medical research center conducting clinical trials across diverse therapeutic areas. The center demonstrates particular expertise in evaluating innovative treatment approaches for complex chronic conditions and surgical interventions, with a focus on improving patient outcomes through evidence-based medicine.
- Diabetic complications and wound healing research, specifically diabetic foot ulcers
- Orthopedic surgery and prosthetic joint infection prevention
- Neurological disorders including primary progressive multiple sclerosis
The center's research portfolio includes investigating antimicrobial therapies for diabetic foot ulcers, developing strategies to prevent prosthetic joint infections through antibiotic-impregnated bone grafts in hip arthroplasty, and evaluating novel BTK inhibitor therapies for neurodegenerative diseases. This multidisciplinary approach positions the center at the forefront of translational medicine, bridging laboratory innovations with clinical applications to address challenging medical conditions affecting both diabetic and orthopedic patient populations, as well as those with progressive neurological disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Region Oestergoetland1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lasarettet I Motala Region Ostergotland
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Tolebrutinib in Primary Progressive Multiple Sclerosis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Genzyme Corp. | Phase III | Not Recruiting | Nov 2020 | Nov 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Saline | 1 | Unknown | 2022-03-18 | 2022-03-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.